Investorideas.com | big ideas for the small cap investor- One of the first online investor resources providing research tools for renewable energy, water and Homeland Security Investing Search www.investorideas.com
   Members       Free Stock Alerts       Stock Quotes        Stock Directories       Stock Research       Green Stocks       MicroCap         News        Video       Funding   




Investing Ideas: Tuesday's NASDAQ Top Percentage Gainers; (KYTH), (NPSP), (AXTI), (MOBI)

Biopharma Stock (KYTH) Leads Gainers

Category: Investment

Ideas get bigger when you share them...

 

Visit: Kythera Biopharmaceuticals Inc.

March 19, 2013 (www.investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors reports on the top percentage gainers on the NASDAQ for March 19th, 2013.

Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner

Kythera Biopharmaceuticals Inc., (NASDAQ:KYTH) trading at $22.37 gained $2.36 or 11.79% on a volume of 50,302 shares, making it today's top percentage gainer on the NASDAQ.

Investorideas.com Newswire

NPS Pharmaceuticals Inc., (NASDAQ:NPSP) trading at $9.97 moved up $0.93 or 10.29% on a high volume of 7,246,027 shares.

NPS Pharmaceuticals Inc. earlier today announced it is regaining the overseas marketing rights to its bowel drug Gattex and another product from Japanese drug maker Takeda

NPS is regaining rights to develop and sell the short bowel syndrome drug Gattex, which is also called Revestive, as well as a hormone drug called Preotact, in all countries. Preotact is approved in Europe as a treatment for post-menopausal osteoporosis, and NPS is trying to get it approved in the U.S. as a treatment for hypoparathyroidism under the name Natpara.

Takeda Pharmaceutical Co. had the right to develop and market the drug in most countries other than the U.S. Takeda will get $50 million in NPS stock, and it can get a milestone payment of $30 million the first year that combined sales of the drugs exceed $750 million. NPS can choose to make that payment in cash or stock.

AXT Inc., (NASDAQ:AXTI) trading at $3.33 rose by $0.24 or 7.62% on a volume of 445,926 shares.

AXT, Inc. stocks rose this morning after RF Micro Devices, a manufacturer of radio frequency solutions, announced a change in its sourcing strategy for a certain type of substrate. RF Micro Devices announced earlier today that it is shifting its sourcing strategy for Gallium Arsenide, or GaAs, solutions by phasing out manufacturing in a U.K. facility and moving most GaAs manufacturing to its facility in Greensboro, NC. RFMD specifically added it will partner with "leading GaAs HBT foundries" for added capacity, though did not name its intended partners. AXT develops and produces substrates made from gallium arsenide, as well as indium phosphide and germanium, according to its corporate profile.

Sky-mobi Limited (NASDAQ:MOBI) trading at $2.00 gained $0.11 or 5.82% on a volume of 86,912 shares.

Investorideas.com Newswire

About NASDAQ

http://www.nasdaq.com/

About InvestorIdeas.com:

InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com

Sign up for the free investor news and stock alerts at Investorideas.com

http://www.investorideas.com/Resources/Newsletter.asp

Or …

Become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in over 14 leading sectors

http://www.investorideas.com/membership/

Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.

BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

800-665-0411 - Source - www.Investorideas.com


Free Investor Stock Alerts
Email:  




TOP

Investor Ideas © 2000 - 2013 InvestorIdeas.com®, ECON

Free Investor Stock Alerts
Sign up here

login | logout | about us | contact | disclaimer / disclosure |
advertise | company profile directory | partners / links |
job search | privacy policy | trade | services | sitemap |